Science Applications International Corporation
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.26B | $7.48B | $7.44B | $7.70B | $7.39B | $7.06B | $6.38B | $4.66B |
| Cost of Revenue | $6.39B | $6.59B | $6.57B | $6.82B | $6.54B | $6.26B | $5.67B | $4.20B |
| Gross Profit | $872.0M | $892.0M | $872.0M | $888.0M | $859.0M | $792.0M | $706.0M | $464.0M |
| Gross Margin | 12.0% | 11.9% | 11.7% | 11.5% | 11.6% | 11.2% | 11.1% | 10.0% |
| Operating Expenses | ||||||||
| Research & Development | $13.0M | $12.0M | $4.0M | $1.0M | $4.0M | $6.0M | $7.0M | $5.0M |
| SG&A Expense | $350.0M | $339.0M | $373.0M | $374.0M | $344.0M | $352.0M | $288.0M | $158.0M |
| Operating Income | $521.0M | $563.0M | $741.0M | $501.0M | $462.0M | $390.0M | $370.0M | $220.0M |
| Operating Margin | 7.2% | 7.5% | 10.0% | 6.5% | 6.2% | 5.5% | 5.8% | 4.7% |
| Interest Expense | — | — | — | $120.0M | $105.0M | $122.0M | $90.0M | $53.0M |
| Pretax Income | $387.0M | $428.0M | $620.0M | $375.0M | $358.0M | $271.0M | $286.0M | $170.0M |
| Income Tax Expense | $29.0M | $66.0M | $143.0M | $72.0M | $79.0M | $60.0M | $57.0M | $33.0M |
| Net Income | $358.0M | $362.0M | $477.0M | $300.0M | $277.0M | $209.0M | $226.0M | $137.0M |
| Net Margin | 4.9% | 4.8% | 6.4% | 3.9% | 3.7% | 3.0% | 3.5% | 2.9% |
| EPS (Basic) | $7.73 | $7.23 | $8.98 | $5.42 | $4.81 | $3.60 | $3.87 | $3.16 |
| EPS (Diluted) | $7.70 | $7.17 | $8.88 | $5.38 | $4.77 | $3.56 | $3.83 | $3.11 |
| Shares Outstanding (Basic) | 46.3M | 50.1M | 53.1M | 55.3M | 57.6M | 58.1M | 58.4M | 43.4M |
| Shares Outstanding (Diluted) | 46.5M | 50.5M | 53.7M | 55.8M | 58.1M | 58.7M | 59.0M | 44.1M |
| Dividends Per Share | $0.37 | $0.37 | $0.37 | $0.37 | $0.37 | $0.37 | $0.37 | $0.31 |